Book Building - SME
₹ 40.68 cr
₹ 79
1600
₹ 1,26,400.00
NSE - SME
19-Feb-2024
22-Feb-2024
27-Feb-2024
Initial public offer of 51,48,800* equity shares of face value of Rs. 10.00 each (Equity Shares) of Zenith Drugs Limited (the Company or the Issuer) for cash at a price of Rs. 79.00 per equity share including a share premium of Rs. 69.00 per equity share (the Issue Price) aggregating to Rs. 40.68 crores (The Issue). The issue includes a reservation of 8,52,800 equity shares aggregating to Rs. 6.74 crores will be reserved for subscription by market maker to the issue (the Market Maker Reservation Portion). The issue less the market maker reservation portion i.e. net issue of 42,96,000 equity shares aggregating to Rs. 33.94 crores (the Net Issue). The issue and the net issue constitute 30.02 % and 25.05 % respectively of the post issue paidup equity share capital of the company. Face value of equity shares is Rs. 10.00 each and the issue price is 7.9 times of the face value. Bid was made for minimum of 1,600 equity shares and the multiples of 1,600 equity shares thereafter*Subject to finalization of basis of allotment
Purchase of Machinery & Equipments for Setting up new unit. Existing manufacturing block upgradation. Working capital requirements. General corporate purposes.
Zenith Drugs Ltd, Office No 56-2, Pinnacle Busine.Park, Mahakali Caves Road, Mumbai - 400093
Phone - 91-22-62638200
Fax - 91-22-63638299
Email - info@zenithdrugs.com
Website - www.zenithdrugs.com